Cleave Therapeutics, Inc.
VCP/p97 Inhibitors for Oncology and Neurodegenerative Diseases
3 employees · est. 2011 · San Francisco, United States
Mural Oncology
Leveraging our protein engineering platform to improve cytokine-based immunotherapies for the treatment of #cancer
112 employees · est. 2023 · Waltham, United States
Cleave Therapeutics, Inc. is the older company (2011 vs 2023); Mural Oncology is the larger of the two.
Side-by-Side Comparison
| Metric | Cleave Therapeutics, Inc. | Mural Oncology |
|---|---|---|
| Founded | ||
| Founded | 2011 older | 2023 |
| Headquarters | ||
| Headquarters | San Francisco, United States | Waltham, United States |
| Employees | ||
| Employees | 3 | 112 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series C | Corporate Round |
| Total Funding | ||
| Total Funding | $91.95M | $275.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | VCP/p97 Inhibitors, Oncology, Neurodegenerative Diseases, Biopharmaceutical, Protein Homeostasis, Cellular Stress Pathways, Cancer Stress Pathways, Drug Discovery, Drug Development, AML (Acute Myeloid Leukemia), Mitochondrial Health, Protein-Degradation Pathways, Small-Molecule Drugs, Selective Inhibitors, Therapeutic Innovation | Immuno-oncology, Cytokine Biology, Cancer, Drug Discovery, Protein Engineering, Immunotherapy, Ovarian Cancer, Melanoma, Nemvaleukin Alfa, Interleukin-18, Interleukin-12, Immune Cell Modulation, Tumor-targeted Therapies, Public Company, Clinical Benefit |
| Website | ||
| Website | cleavetherapeutics.com | muraloncology.com |
About Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc., founded in 2011, is a pioneering biopharmaceutical company headquartered in the United States. It focuses on developing VCP/p97 inhibitors for applications in oncology and neurodegenerative diseases. The company positions itself as a leader in targeting the valosin-contain...
About Mural Oncology
Mural Oncology, founded in 2023, is a healthcare startup based in the United States. The company focuses on leveraging its protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Their slogan, "Leveraging our protein engineering platform to improve c...
We will tell you when either one moves
BounceWatch watches Cleave Therapeutics, Inc. and Mural Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cleave Therapeutics, I... and Mural Oncology — by email.
Frequently Asked Questions
Compare Cleave Therapeutics, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Cleave Therapeutics, Inc. on 11 Mar 2026, and Mural Oncology on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
